Source:http://linkedlifedata.com/resource/pubmed/id/21166654
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2011-3-18
|
pubmed:abstractText |
The aim of this study is to investigate whether PI3K (phosphatidylinositol-3-kinase) is involved in IL-1? (interleukin-1?)-induced IL-6 production in A549 (human lung adenocarcinoma epithelial cell) and human RASF (rheumatoid arthritis synovial fibroblast). PI3K inhibitor, LY294002 significantly reduced IL-1?-induced IL-6 production in A549 cells but not in RASF, indicating that IL-1?-induced IL-6 production was partially mediated by PI3Kin A549 cells but not in RASF. siRNA (small interfering RNA) of IRAK4 (IL-1 receptor-associated kinase 4) treatment decreased IRAK4 mRNA level by up to 90% in A549 cells. In this condition, IL-1?-induced increase of IL-6 mRNA and protein level was decreased by up to 93% and 70%, respectively. Furthermore, the combination of IRAK4 siRNA and LY294002 treatment decreased protein induction level of IL-6 in A549 cells compared with that of IRAK4 siRNA or LY294002 alone. These results indicate that IL-1?-induced IL-6 production in A549 cells is mediated by both PI3K and IRAK4 and suggest that involvement of PI3K in the IL-1-induced IL-6 production is cell type specific.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1 Receptor-Associated...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1beta,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1095-8355
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
355-8
|
pubmed:meshHeading |
pubmed-meshheading:21166654-Arthritis, Rheumatoid,
pubmed-meshheading:21166654-Cell Line,
pubmed-meshheading:21166654-Cell Line, Tumor,
pubmed-meshheading:21166654-Epithelial Cells,
pubmed-meshheading:21166654-Fibroblasts,
pubmed-meshheading:21166654-Humans,
pubmed-meshheading:21166654-Interleukin-1 Receptor-Associated Kinases,
pubmed-meshheading:21166654-Interleukin-1beta,
pubmed-meshheading:21166654-Interleukin-6,
pubmed-meshheading:21166654-Lung,
pubmed-meshheading:21166654-Phosphatidylinositol 3-Kinase
|
pubmed:year |
2011
|
pubmed:articleTitle |
Interleukin-1?-induced interleukin-6 production in A549 cells is mediated by both phosphatidylinositol 3-kinase and interleukin-1 receptor-associated kinase-4.
|
pubmed:affiliation |
Discovery Biology, Global Research and Development, St. Louis Laboratories Pfizer Inc., 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA. hiroyuki_eda@ajinomoto.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|